Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells.
about
Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticlesTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerMetallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis.Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance.RAB8 enhances TMEM205-mediated cisplatin resistance.Extensive disease small cell lung cancer dose-response relationships: implications for resistance mechanisms.Endocytic recycling compartments altered in cisplatin-resistant cancer cells.Copper transporter 2 regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo.Down-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines.Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy.The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatin.Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells.SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolismDecitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors.Identification of hypermethylated genes associated with cisplatin resistance in human cancersFOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells.
P2860
Q27026080-07CDEC85-0707-4184-B846-DEDC88882570Q28396304-21A6631D-88AA-4C6A-A5AA-FDA3EDE86DB5Q30494430-425F46AD-4D57-40D6-A360-87A4D41F7E8CQ33230937-4847236F-FC9F-4EF4-A62C-74A58A4F68A3Q34221132-9F3F102E-E22D-4C99-9C12-5E883B19D9C0Q34252309-294D49EE-2B30-461F-9384-8C1F632E9A4FQ34406800-2F99FC59-F7B5-4F90-AD1C-84F9B1021DB0Q34458507-8706E9D4-13C9-49B4-8C2A-B1DD7AC6545DQ34468400-1AD0D7DA-630E-4F42-A549-FF7DD79B3E08Q35212176-CDFD1A55-0FC2-460A-BD35-33126B0BE65CQ36008522-0A0BEACA-4054-4946-BAE5-91CDFCEAC116Q36105474-9C487DC8-1AF0-4CE3-9650-3D7958333952Q36405766-1550C2AE-B378-4191-BDDE-1B153CA68665Q36585797-DAB10C55-CE28-44BB-8306-446F7DA8D20DQ37002755-E934A1C9-9F16-4184-B870-9B77AF2A7EAAQ37493954-05BE6D00-9D41-424B-A228-7225649FF7FBQ39730118-ED6EFD91-8BF2-4850-A7B9-AAE523FEC4E7Q49869601-4D236788-31FA-4531-9C48-0865E4F47C6D
P2860
Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Reduced expression of small GT ...... in cisplatin-resistant cells.
@ast
Reduced expression of small GT ...... in cisplatin-resistant cells.
@en
type
label
Reduced expression of small GT ...... in cisplatin-resistant cells.
@ast
Reduced expression of small GT ...... in cisplatin-resistant cells.
@en
prefLabel
Reduced expression of small GT ...... in cisplatin-resistant cells.
@ast
Reduced expression of small GT ...... in cisplatin-resistant cells.
@en
P2093
P2860
P356
P1476
Reduced expression of small GT ...... in cisplatin-resistant cells.
@en
P2093
A Pai-Panandiker
M M Gottesman
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601956
P407
P577
2004-07-01T00:00:00Z